Skip to main content
Caplight Logo









Stimunity

Stimunity

Private
ParisHealthcare & Life Scienceshttps://stimunity.com/

Last Round

Seed

May 11, 2020

Total Funding Raised

$4.46M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Stimunity is a biotechnology company that develops drugs on the STING pathway to activate the innate immune system to fight cancer and infectious pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immuno-oncologySTING agonistvirus-like particleVLPcancer immunotherapydrug delivery platformbiotech startupcGAMPpreclinical biotechtargeted therapyinnate immune systemdrug licensingbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stimunity Comparables

Compare Stimunity with similar companies based on industry and business-model similarity.

Stimunity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Saros Therapeutics
83%
Portage Biotech Inc
81%
ImmuneSensor Therapeutics
76%

Stimunity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 11, 2020
GrantOct 21, 2019
GrantMar 25, 2019
SeedMar 25, 2019
SeedFeb 28, 2018
Grant
Jul 10, 2017

Stimunity Investors

Notable investors and investment history

Stimunity investors
InvestorRounds
Région Île-de-FranceGrant
European CommissionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors grew 345% MoM, from 248 to 1.1K.

  • May 11, 2020

    $990K round led by Portage Biotech Inc

Stimunity Filings

Explore SEC and related filing metadata, where available.

Stimunity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stimunity's valuation, stock price, and market status.

Is Stimunity a public or private company?

Stimunity is a private company.

What is the current stock price of Stimunity?

Stimunity is a private company with no public stock price. Caplight tracks Stimunity's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Stimunity worth (valuation)?

Valuation information for Stimunity is not publicly available.

Can I buy Stimunity stock?

Stimunity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stimunity's last funding round?

Stimunity's most recent funding round was Seed on May 11, 2020.

Who are the main investors in Stimunity?

Key investors in Stimunity include Région Île-de-France, European Commission.

Will Stimunity IPO soon?

No public IPO plans have been announced for Stimunity.

How can I track Stimunity secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stimunity's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range2
Year Founded2016
Last FundingMay 11, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?